Bayesian doubly adaptive randomization in clinical trials
From MaRDI portal
Recommendations
- Bayesian adaptive methods for clinical trials
- Bayesian adaptive designs for clinical trials
- Bootstrapped Bayesian analyses of two adaptive clinical trials
- scientific article; zbMATH DE number 4155731
- Bayesian randomized clinical trials: A decision-theoretic sequential design
- A Bayesian Approach to the Design of Phase II Clinical Trials
- Bayesian bandits in clinical trials
- A Bayesian adaptive design for clinical trials in rare diseases
Cites work
- scientific article; zbMATH DE number 1817583 (Why is no real title available?)
- Asymptotic properties of adaptive designs for clinical trials with delayed response
- Asymptotic properties of covariate-adaptive randomization
- Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials.
- Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses
- Bayesian adaptive designs for clinical trials
- Central limit theorems for doubly adaptive biased coin designs
- Doubly adaptive biased coin designs with delayed responses
- Efficient randomized-adaptive designs
- Immigrated urn models-theoretical properties and applications
- Implementing Optimal Allocation in Sequential Binary Response Experiments
- Optimality, Variability, Power
- Sequential monitoring of response-adaptive randomized clinical trials
- The Randomized Play-the-Winner Rule in Medical Trials
- The Theory of Response‐Adaptive Randomization in Clinical Trials
- The doubly adaptive biased coin design for sequential clinical trials
Cited in
(11)- Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes
- A Markov decision process for response-adaptive randomization in clinical trials
- A Bayesian adaptive design for clinical trials in rare diseases
- Comment: a quarter century of methodological research in response-adaptive randomization
- Bayesian uncertainty directed trial designs
- Doubly adaptive biased coin design to improve Bayesian clinical trials with time-to-event endpoints
- Bayesian bandits in clinical trials
- Bayesian adaptive randomization with compound utility functions
- Comment: is response-adaptive randomization a ``good thing or not in clinical trials? Why we cannot take sides
- Rejoinder: response-adaptive randomization in clinical trials
- Covariate-adaptive randomization with variable selection in clinical trials
This page was built for publication: Bayesian doubly adaptive randomization in clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q681928)